8696879946_c47d0f98fa_o.jpg
cells14.jpg
cells1.jpg
8696879946_c47d0f98fa_o.jpg

Our biotech finance handbook


SCROLL DOWN

Our biotech finance handbook


 

BUY IT on amazon

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is your one-stop reference to make investment decisions, pitch to potential partners, or estimate the value of an R&D program.

 

"Deserves a spot on the bookshelf of every biotech CFO."

- Bruce Booth, Partner, Atlas Venture

 

Download a free sample chapter: Projecting Market Share for R&D-Stage Biotechs

Read the table of contents and get more details here

cells14.jpg

Discover how far you can go.


SCROLL DOWN

Discover how far you can go.


 

Pharmagellan unlocks the true value in your biotech development pipeline.


Many early-stage drug development projects don't progress if the team is stretched thin, and people and resources are focused on more advanced assets.

To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.

Pharmagellan offers just that: expert advice and project execution to biotech and pharma companies willing to discover how far they can go. Learn more about what we do and how we can help.

 


Research
& Development

Preclinical, translational, and early clinical strategy and execution

 

commercial
& Corporate

Competitive and financial analysis of products, portfolios, and companies

 
cells1.jpg

Research highlights


SCROLL DOWN

Research highlights